What Noom changed

• Added new blog posts about clinical weight loss, including "Oral tirzepatide drops" and "Does Diet Coke break a fast?"
• Added content addressing viral trends like the "baking soda trick" for weight loss.
• Updated the blog feed to include seasonal nutrition topics like butternut squash and low-calorie Dunkin’ drinks.
• Removed older blog entries about matcha recipes and walnuts.

Noom is shifting its content strategy to focus heavily on medical weight loss (GLP-1s) and debunking viral health trends. This helps them capture search traffic from people looking for clinical solutions or checking the safety of popular social media health hacks.

• Updated the blog feed to feature new articles about Mounjaro timelines, Zepbound side effects, and injection methods.
• Changed the primary "See if you qualify" link for weight-loss medication from a general survey to a specific clinical landing page.
• Removed detailed pricing text from the footer disclaimer, leaving it truncated.
• Replaced older blog posts about Wegovy and general nutrition with more recent content from late September 2026.

Noom is shifting its marketing focus toward specific medications like Mounjaro and Zepbound. They are also changing where they send potential customers to qualify for clinical programs, which may impact their conversion rates.

• Added a "MEDICARE GLP-1 COVERAGE" link to the main navigation.
• Updated the pricing disclaimer to specify a $149 initial cost and $349 monthly rate for new accounts.
• Removed the "Personality Quiz" from the primary navigation menu.
• Updated the blog section with new articles focused on the Wegovy pill, Zepbound timing, and preventing muscle loss.
• Changed the featured user testimonial video from "Video 3" to "Video 4."

Noom is expanding its reach to the older demographic by helping Medicare users navigate drug coverage. They also updated their pricing terms and shifted their content focus toward the Wegovy pill and muscle loss prevention during medication use.